Nombre del producto:7-tert-butyl-3-(2,5-difluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine

IUPAC Name:5-({[7-tert-butyl-3-(2,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}methyl)-1-methyl-1H-1,2,4-triazole

CAS:286456-42-6
Fórmula molecular:C19H19F2N7O
Pureza:95%+
Número de catálogo:CM338507
Peso molecular:399.41

Unidad de embalaje Stock disponible Precio($) Cantidad
CM338507-100mg 4-5 Weeks NJưNJ
CM338507-250mg 5-6 Weeks ƓƓȎů

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :286456-42-6
Fórmula molecular:C19H19F2N7O
Punto de fusión:-
Código de sonrisas:CN1N=CN=C1COC2=NN3C(C=C2C(C)(C)C)=NN=C3C4=CC(F)=CC=C4F
Densidad:
Número de catálogo:CM338507
Peso molecular:399.41
Punto de ebullición:
Nº Mdl:MFCD08690609
Almacenamiento:2-8°C

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products